高级检索
    李益清, 马丽萍, 邓程新. 联合应用组蛋白脱乙酰基酶抑制剂对治疗相关髓系肿瘤疗效不佳[J]. 循证医学, 2017, 17(2): 78-80. DOI: 10.12019/j.issn.1671-5144.2017.02.005
    引用本文: 李益清, 马丽萍, 邓程新. 联合应用组蛋白脱乙酰基酶抑制剂对治疗相关髓系肿瘤疗效不佳[J]. 循证医学, 2017, 17(2): 78-80. DOI: 10.12019/j.issn.1671-5144.2017.02.005
    shu
    LI Yi-qing, MA Li-ping, DENG Cheng-xin. Combined Use of HDAC Inhibitors in the Treatment of Myeloid Associated Tumor Curative Effect Is Poor[J]. Journal of Evidence-Based Medicine, 2017, 17(2): 78-80. DOI: 10.12019/j.issn.1671-5144.2017.02.005
    Citation: LI Yi-qing, MA Li-ping, DENG Cheng-xin. Combined Use of HDAC Inhibitors in the Treatment of Myeloid Associated Tumor Curative Effect Is Poor[J]. Journal of Evidence-Based Medicine, 2017, 17(2): 78-80. DOI: 10.12019/j.issn.1671-5144.2017.02.005
    shu

    联合应用组蛋白脱乙酰基酶抑制剂对治疗相关髓系肿瘤疗效不佳

    Combined Use of HDAC Inhibitors in the Treatment of Myeloid Associated Tumor Curative Effect Is Poor

      摘要
      • HTML全文
      • 参考文献(1)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回